000279294 001__ 279294
000279294 005__ 20240619092059.0
000279294 0247_ $$2doi$$a10.1371/journal.pone.0127865
000279294 0247_ $$2Handle$$a2128/9549
000279294 0247_ $$2WOS$$aWOS:000355319400055
000279294 0247_ $$2altmetric$$aaltmetric:4153113
000279294 0247_ $$2pmid$$apmid:26024352
000279294 037__ $$aFZJ-2015-07309
000279294 082__ $$a500
000279294 1001_ $$0P:(DE-Juel1)144676$$aWolff, Martin$$b0
000279294 245__ $$aAmyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation
000279294 260__ $$aLawrence, Kan.$$bPLoS$$c2015
000279294 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1449670317_32510
000279294 3367_ $$2DataCite$$aOutput Types/Journal article
000279294 3367_ $$00$$2EndNote$$aJournal Article
000279294 3367_ $$2BibTeX$$aARTICLE
000279294 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000279294 3367_ $$2DRIVER$$aarticle
000279294 520__ $$aAlzheimer’s disease (AD)-associated amyloid β peptide (Aβ) is one of the main actors in AD pathogenesis. Aβ is characterized by its high tendency to self-associate, leading to the generation of oligomers and amyloid fibrils. The elucidation of pathways and intermediates is crucial for the understanding of protein assembly mechanisms in general and in conjunction with neurodegenerative diseases, e.g., for the identification of new therapeutic targets. Our study focused on Aβ42 and its oligomeric assemblies in the lag phase of amyloid formation, as studied by sedimentation velocity (SV) centrifugation. The assembly state of Aβ during the lag phase, the time required by an Aβ solution to reach the exponential growth phase of aggregation, was characterized by a dominant monomer fraction below 1 S and a population of oligomeric species between 4 and 16 S. From the oligomer population, two major species close to a 12-mer and an 18-mer with a globular shape were identified. The recurrence of these two species at different initial concentrations and experimental conditions as the smallest assemblies present in solution supports the existence of distinct, energetically favored assemblies in solution. The sizes of the two species suggest an Aβ42 aggregation pathway that is based on a basic hexameric building block. The study demonstrates the potential of SV analysis for the evaluation of protein aggregation pathways.
000279294 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000279294 588__ $$aDataset connected to CrossRef
000279294 7001_ $$0P:(DE-HGF)0$$aUnuchek, Dmitry$$b1
000279294 7001_ $$0P:(DE-Juel1)151345$$aZhang, Bo$$b2$$ufzj
000279294 7001_ $$0P:(DE-Juel1)131964$$aGordeliy, Valentin$$b3$$ufzj
000279294 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b4$$ufzj
000279294 7001_ $$0P:(DE-Juel1)162443$$aNagel-Steger, Luitgard$$b5$$eCorresponding author$$ufzj
000279294 773__ $$0PERI:(DE-600)2267670-3$$a10.1371/journal.pone.0127865$$gVol. 10, no. 5, p. e0127865 -$$n5$$pe0127865$$tPLoS one$$v10$$x1932-6203$$y2015
000279294 8564_ $$uhttps://juser.fz-juelich.de/record/279294/files/Amyloid%20%CE%B2%20Oligomeric%20Species%20Present%20in%20the%20Lag%20Phase%20of%20Amyloid%20Formation.pdf$$yOpenAccess
000279294 8564_ $$uhttps://juser.fz-juelich.de/record/279294/files/Amyloid%20%CE%B2%20Oligomeric%20Species%20Present%20in%20the%20Lag%20Phase%20of%20Amyloid%20Formation.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000279294 8767_ $$92015-06-15$$d2015-06-16$$eAPC$$jDeposit$$lDeposit: PLoS
000279294 909CO $$ooai:juser.fz-juelich.de:279294$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000279294 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)151345$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000279294 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131964$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000279294 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000279294 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)162443$$aForschungszentrum Jülich GmbH$$b5$$kFZJ
000279294 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000279294 9141_ $$y2015
000279294 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000279294 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000279294 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000279294 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000279294 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPLOS ONE : 2014
000279294 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000279294 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000279294 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000279294 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000279294 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000279294 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000279294 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000279294 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000279294 920__ $$lyes
000279294 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000279294 9201_ $$0I:(DE-Juel1)ICS-1-20110106$$kICS-1$$lNeutronenstreuung $$x1
000279294 9801_ $$aUNRESTRICTED
000279294 9801_ $$aFullTexts
000279294 980__ $$ajournal
000279294 980__ $$aVDB
000279294 980__ $$aUNRESTRICTED
000279294 980__ $$aI:(DE-Juel1)ICS-6-20110106
000279294 980__ $$aI:(DE-Juel1)ICS-1-20110106
000279294 980__ $$aAPC
000279294 981__ $$aI:(DE-Juel1)IBI-7-20200312
000279294 981__ $$aI:(DE-Juel1)IBI-8-20200312
000279294 981__ $$aI:(DE-Juel1)JCNS-1-20110106
000279294 981__ $$aI:(DE-Juel1)ICS-1-20110106